Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-25

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)

View source ↗

Summary

FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, granting approval for the supplemental use of this generic product. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)